Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 122   

Articles published

GSK 1,451.53 -5.47 (-0.38%)
price chart
There has never been a better time to buy GlaxoSmithKline plc, Persimmon plc ...
If you are investing in shares, what do you look for? Well, I would say a key component is growth: increasing revenues and increasing earnings.
Lloyds Banking Group plc vs GlaxoSmithKline plc: which is the better growth stock?
But regardless of which stock you may personally prefer, I believe both Lloyds and GlaxoSmithKline provide great value relative to their long-term growth prospects, the firms dealing on prospective P/E ratings of 9.3 times and 16.1 times respectively ...
How Pennon Group plc (3.91%) could soon yield more than GlaxoSmithKline plc (5 ...
When comparing company dividends, you need to do more than simply look at today's headline yield. In these uncertain times, with a number of big-name FTSE 100 companies slashing their payouts over the last year, you need to see how well that dividend ...
Is GlaxoSmithKline plc a better dividend buy than Standard Life plc and Legal ...
While GlaxoSmithKline (LSE: GSK) has a relatively high yield of 5.5%, one concern among investors is its lack of forecast dividend growth.
GlaxoSmithKline plc (NYSE:GSK) & Intrexon Corp (NYSE:XON) Healthcare ...  Wall Street 24
Glaxosmithkline Plc (NYSE:GSK) Sellers Increased By 15.53% Their Shorts  Franklin Independent
Are GlaxoSmithKline plc, Tissue Regenix Group plc and Optibiotix Health plc ...
City analysts forecast an earnings rise of 15%, and this is expected to be just the start of a new growth trajectory. As such, Glaxo appears an attractive buy at a current share price of 1,436p on a price-to-earnings ratio of 16.4 and with a dividend ...
Time to buy GlaxoSmithKline plc and Carillion plc?
Today I'll be taking a closer look at construction services company Carillion (LSE: CLLN), and pharmaceuticals giant GlaxoSmithKline (LSE: GSK). Is it the right time to invest in these Great British businesses?
Longer lives, bigger profits: Why I'm bullish on GlaxoSmithKline plc ...  AOL Money UK
You could beat the market with GlaxoSmithKline plc and Shire plc
GlaxoSmithKline (LSE: GSK) and Shire (LSE: SHP) are two such companies. Shire is a world-leading producer of rare disease treatments, and the company is unlikely to be displaced from this position anytime soon.
GlaxoSmithKline plc (ADR) Moves Ahead in COPD Treatment
GlaxoSmithKline's plc (NYSE:GSK) new inhale formulation has shown comprehensive results when compared to the standard of care (SOC) treatment for patients suffering from chronic obstructive pulmonary disease (COPD).
GlaxoSmithKline plc (NYSE:GSK) Breo Gains New Hope From Recent Study  Market Exclusive
GlaxoSmithKline hails progress with lung disease treatment  Proactive Investors UK
Are Aviva plc, GlaxoSmithKline plc and Royal Dutch Shell plc the FTSE 100's ...
GlaxoSmithKline has seen earnings slide during the past four years as exclusivity lapses across key products have dented revenues growth.
Why is Neil Woodford so bullish on drugmakers GlaxoSmithKline plc, AstraZeneca ...
Neil Woodford's Equity Income Fund is heavily weighted towards healthcare companies, and GlaxoSmithKline (LSE: GSK) makes up 6.3% of this entire fund. Woodford hasn't only been buying the company for its 5%-plus dividend though, but also sees great ...